Abbisko Cayman (HKG:2256) Founder Xu Yao-Chang purchased 40,000 shares at HK$7.57 apiece, according to a Thursday filing with the Hong Kong bourse.
The purchased shares represent 0.01% of the total shareholding of the drug company.
Following the purchase, Xu, who is also the chairman and CEO, has an aggregate of 79,987,980 shares, equivalent to 11.77% of the total issued shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.